Document is current
Any future updates will be listed below
-
Authors
Yan, Yan
Han, Yichao
Niu, Zhenyi
Zhang, Xianfei
Li, Chengqiang
Cao, Yuqin
Yin, Zhengxin
Zhu, Lianggang
Hang, Junbiao
Che, Jiaming
Ren, Jian
Xiang, Jie
Chen, Kai
Du, Hailei
Han, Dingpei
Yang, Xiaoqing
Zhang, Yajie
Chen, Xueyu
Jing, Hui
Yu, Shengjia
Wang, Xiaofeng
Guo, Zengya
Chen, Xiaoyan
Luo, Fangxiu
Zhong, Wenzhao
Jin, Runsen
Li, Hecheng https://orcid.org/0000-0001-8069-6033
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04945928 at ClinicalTrials.govDocuments that mention this clinical trial
Conversion Surgery After Induction Therapy for Initially Unresectable Stage III Non-small Cell Lung Cancer: A Proof-of-Concept Trial
https://doi.org/10.1245/s10434-026-19461-z
-
Funding
Funding for this research was provided by:
Natural Science Foundation of Shanghai Municipality (22ZR1439200)
Shanghai Leading Talent Program from Shanghai Municipal Commission of Commerce
National Key Research and Development Program of China (2021YFC2500900)
Shanghai Jiao Tong University (YG2023ZD04)
National Natural Science Foundation of China (82072557)
National Natural Science Foundation of China (82372855)
Shanghai Municipal Health Commission (2022JC023)
- License Information
-
More Information
Article History
Received: 5 November 2025
Accepted: 25 February 2026
First Online: 25 March 2026
Disclosure
: All the authors declare no conflict of interest.
: Ethics approval has been obtained from Ruijin Hospital Ethics Committee on 10 November 2020 (approval no. 2020.344).
: Written informed consent was obtained from all the patients prior to participation.
